Template:Heparin-induced thrombocytopenia: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 145: Line 145:
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
!
[[Heparin-induced thrombocytopenia primary prevention|Primary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Heparin-induced thrombocytopenia secondary prevention|Secondary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Heparin-induced thrombocytopenia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Heparin-induced thrombocytopenia future or investigational therapies|Future or Investigational Therapies]]
|-
!


|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"

Revision as of 21:58, 2 June 2016